Why SIBO comes back: the cleaning wave, underlying causes and prokinetics
After successful treatment, small intestinal bacterial overgrowth returns in many people. What the small intestine’s cleaning wave has to do with it, which causes are worth looking for, and what drugs that stimulate gut movement can do.
How solid is the research? Trust score 2 of 5:Plausible
That SIBO often comes back after treatment, and that impaired gut movement plays a part, is well supported by cohort studies. How to prevent relapses is barely studied: for prokinetics there are almost only retrospective analyses and small studies, mostly from single centres.
Cause or consequence? Root cause 4 of 5:Often a cause
The cleaning wave of the fasting phases clears the small intestine and keeps germs down. When it weakens — through a damaged vagus nerve, medication or a sluggish stomach — germs rise and the overgrowth comes back. That is why it often stands right at the start of a relapse.
Healthy state
The small intestine has its own cleaning crew. When you are fasting, the Migrating motor complex A wave of muscle contractions that sweeps the stomach and small intestine empty about every one and a half to two hours when fasting. Eating interrupts it. More in the chapter “Intermittent fasting and meal timing: 16:8, 5:2 and Ramadan”, MMC for short, runs roughly every 90 to 120 minutes. It has three phases: a quiet phase, a phase of irregular contractions and finally a few minutes of strong, regular contractions that travel from the stomach to the end of the small intestine. This third phase is the actual cleaning wave.
The wave is controlled by the nervous system of the gut wall and by hormones, above all motilin, which is released in bursts from the duodenum while you are fasting. Every meal switches the pattern off and replaces it with digestive movements. The antibiotic erythromycin binds to the motilin receptor and can trigger a wave this way. That is why it is used at low doses to stimulate gut movement.
The wave is not the only protection. Stomach acid, bile, digestive enzymes, defences such as IgA (secretory IgA) The antibody of the mucous membranes. It is released into the gut in large amounts, where it holds germs in the mucus without causing inflammation. More in the chapter “IgA: the antibody that keeps the gut clean, and what vitamin A, D and omega-3 have to do with it” and the valve to the large intestine also keep bacterial numbers in the upper small intestine low. If one of these mechanisms fails, the others partly compensate. If several fail, the risk of overgrowth rises considerably.
When people think of Small intestinal bacterial overgrowth (SIBO) Too many bacteria in the small intestine, where normally few live. Bloating and diarrhoea are typical; it is usually diagnosed with a breath test. More in the chapter “When the small intestine is too densely colonised”, they usually think of the bacteria. For lasting success, though, the more important question is why they were able to settle in the small intestine. The US society AGA therefore explicitly advises looking for causes and correcting them where possible, rather than only fighting the bacteria.
Disrupted state: causes and effects
Relapses are common. In an Italian study of 80 people whose Breath test After drinking a sugar solution, hydrogen and methane in the breath are measured several times. This can reveal sugar intolerances and signs of bacterial overgrowth. More in the chapter “Gut tests: what they show and what they do not” was normal after one week of rifaximin, it was positive again in 13 percent after three months, 28 percent after six months and 44 percent after nine months. Overgrowth returned more often with older age, after removal of the appendix and with long-term use of acid blockers. Symptoms came back along with the positive test.
It is similar in Irritable bowel syndrome Recurring abdominal pain linked to bowel movements, without tests finding another cause. Today it is understood as a disorder of gut–brain interaction. More in the chapter “The gut-brain axis” with diarrhoea: of 1074 people helped by a course of rifaximin, 64 percent had symptoms again within 18 weeks. A second course helped 38 percent, Placebo A dummy treatment without an active ingredient. Comparing with it shows how much a remedy achieves beyond expectation and chance. 32 percent. Antibiotics relieve symptoms, but they rarely remove the cause.
A weak cleaning wave is one of the most important causes. In a measurement study, 68 people with IBS and an abnormal breath test had on average 0.7 cleaning waves in four fasting hours, compared with 2.2 in 30 healthy people. In those whose overgrowth had already been treated, movement was partly more normal again. What is cause and what is effect is not fully settled.
The wave weakens with nerve damage from long-standing diabetes, with opioids, with diseases of the gut muscle such as scleroderma and probably after severe gut infections. In rats, morphine stopped the cleaning wave and bacteria multiplied in the small intestine. An underactive thyroid also slows the gut: in small-bowel samples, 33 percent of people with hypothyroidism had overgrowth, compared with 15 percent without. In a large US database, the risk appeared lower in people treated with thyroid hormone. An older analysis of breath tests found the opposite, but the newer study is based on samples taken directly from the small intestine and is therefore more reliable.
Then there are causes no motility drug can fix: adhesions after abdominal surgery, narrowings such as in Crohn’s disease, pouches in the small intestine, blind loops after stomach or bowel surgery, and a removed or poorly closing valve to the large intestine. In a Meta-analysis An analysis that combines the results of several studies. It is only as good as the studies it includes. , acid blockers raised the risk by about 1.7 times. In a cross-sectional study from India, people taking a Prokinetics Drugs that stimulate movement of the stomach and gut, such as prucalopride or low-dose erythromycin. alongside their acid blocker had SIBO less often than people on an acid blocker alone, 1.8 versus 13.2 percent.
Support groups and forums recommend many things for prevention: long breaks between meals, ginger, Iberogast, strict long-term diets, repeated herbal courses and prescription prokinetics. There is hardly any study evidence for them. The best studied are low-dose erythromycin and tegaserod, which was available at the time: in a retrospective analysis, people stayed symptom-free longer with them than without prevention. Tegaserod is no longer available in most countries.
Where it comes from and where it leads
The same symptoms can have different roots. This map shows what may be involved in this problem and what may follow from it.
Possible causes. Vagus nerve, Medication, Gastroparesis, Stress & sleep, Long Covid, POTS & connective tissue, Autoimmunity, Gut immunity. Possible consequences. SIBO, Weak digestion, Methane & H₂S, Leaky barrier, Low DAO, Histamine, Intolerance, Brain fog & fatigue, Bloating, Diarrhoea, Abdominal pain, Nutrient deficiency, Constipation, Inflammation, Skin & gut, Food fear
- Possible causes
- This problem
- Possible consequences
The preview fits the screen width. In the large map you see everything at once.
Move the mouse over a box: its connections are highlighted and everything else steps back.
Tap a box to highlight its connections. Tap it again to open the chapter.
Connections, not certainty: a link means “can”, not “must”. What applies to you is best clarified in a talk with your doctor.
What often helps
Lifestyle
Diet, exercise, sleep, social contact and dealing with stress.
- Leave three to four hours between meals The cleaning wave only runs when the stomach is empty. Three meals with breaks and a night-time break of about 12 hours give it a chance. Whether this prevents relapses has not been tested in studies; it is based on physiology and is safe for most people. If you use insulin or are underweight, discuss it first. Plausible How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [1]
- No strict long-term diet for prevention No study shows that a permanently strict diet prevents relapses. It can, however, lead to deficiencies, less diversity in the gut flora and fear of eating. Low-FODMAP is meant as a limited phase followed by reintroduction, not as a permanent solution. Plausible How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [2]
Natural supplements
Supplements do not replace a medical check-up. Discuss dosage and interactions with your doctor or pharmacist.
- Ginger In a study of 24 healthy people, ginger sped up gastric emptying and stimulated movement at the stomach outlet. Whether it strengthens the cleaning wave in the small intestine or prevents relapses has not been studied. As a spice or tea there is little against it; if you take blood thinners, ask your doctor before using capsules. Plausible How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [3]
- Iberogast (STW 5) This herbal combination relieved abdominal pain better than placebo in 208 people with IBS, and it is well studied for a sensitive stomach. There is no study on SIBO or on the cleaning wave. The classic formula contains greater celandine, which in rare cases damages the liver; do not use it with liver disease without talking to your doctor. A celandine-free version also exists (STW 5-II); the same applies to it for SIBO. Plausible How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [4][5][6]
Medical treatments
Information, not a treatment recommendation. Decide together with a doctor. Approval and availability differ from country to country.
- Have the cause investigated Ask for a targeted search: review your medicines, check thyroid and blood sugar, mention previous operations, and get imaging if adhesions, narrowings or pouches are suspected. With weight loss, anaemia, blood in the stool or new symptoms from about age 50, an endoscopy is part of it. Promising How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [7][8]
- Review acid blockers and opioids If you take acid blockers or opioids long term, discuss with your doctor whether you still need them or whether there are alternatives. Do not stop acid blockers on your own; plan with your doctor whether to stop step by step or all at once. Promising How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [9][10]
- Treat the thyroid An underactive thyroid slows the gut. When it was recognised and treated, the SIBO risk appeared lower in a large data analysis. A TSH blood test is simple and especially worthwhile if you have tiredness, sensitivity to cold and constipation. Promising How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [11]
- Prucalopride: discuss with your doctor Prucalopride stimulates movement throughout the gut via serotonin receptors and is recommended in guidelines for chronic constipation. In 40 people with scleroderma it shortened transit time through the small intestine; 7 stopped because of side effects such as headache, diarrhoea or cramps. A study on preventing SIBO relapses is missing. Prescription only and with medical supervision. Plausible How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [12][13]
- Low-dose erythromycin: weigh benefits and risks Taken at a low dose at night, it is meant to trigger the cleaning wave. This is supported only by a retrospective analysis. Erythromycin is an antibiotic: it can promote resistance, change heart rhythm and interact with many medicines. At normal antibiotic doses, the risk of sudden cardiac death was doubled in a large study. Not for self-experiments, only after a medical check, for example with an ECG and a review of your medicines. Plausible How we rate the evidence Established Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies. Well supported Several randomised studies in humans with largely consistent results. Promising Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies. Plausible Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms. Experimental Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open. [14][15]
From the community: what people report
Experiences and tips from people with the same problems that come up again and again, but for which there are no meaningful studies yet. They are explicitly not evidence.
Prokinetics long-term, usually in the evening
Many report that after treatment they take a medication that stimulates bowel movement (a prokinetic) on an ongoing basis, usually in the evening in a low dose and sometimes for months, to prevent a relapse. As the biggest hurdle they name that the prescription-only version is often not covered by insurance or is refused by physicians. Some therefore turn to herbal mixtures with ginger and artichoke, while others obtain medications on their own – the latter is problematic both legally and medically.
Relapse as the expected norm
Very many report that the complaints returned weeks to months after stopping, sometimes after a single phase of "slip-ups" with food, and that several rounds of treatment were needed. The assessment recurs that a diet alone does not prevent a relapse and remains of little lasting value without resolved gut motility. Some, by contrast, report having remained symptom-free for years with consistent follow-up care.
"Die-off" as an interpretation of a worsening
Many report that their complaints clearly worsened at the start of treatment and interpret this as "die-off" or a cleansing reaction, that is, the dying off of the bacteria; some encourage each other to push through. In the same threads, others explicitly doubt this: a worsening could also mean that the remedy does not fit or the dose is too high, and some stopped for this reason. For small intestinal bacterial overgrowth this concept is not supported by evidence – a worsening is always a reason to question the treatment.
Personal reports can mislead: what helps many people may be a placebo, and what helps one may harm another. Treat them as ideas to raise with your doctor or pharmacist – not as instructions.
In the mood for something completely different? Another one, at random
How we rate the evidence
- Trust score 5 of 5:Established
- Recommended in medical guidelines or supported by several consistent meta-analyses of randomised human studies.
- Trust score 4 of 5:Well supported
- Several randomised studies in humans with largely consistent results.
- Trust score 3 of 5:Promising
- Single randomised or controlled studies in humans, not yet independently confirmed — or many consistent observational studies.
- Trust score 2 of 5:Plausible
- Two cases: first observational or pilot studies with small samples — or a settled basis that is not in dispute, such as movement, sleep or meal pauses. But not tested in humans for symptoms.
- Trust score 1 of 5:Experimental
- Barely studied in humans. Mainly lab and animal studies or theoretical reasoning; whether it helps is open.
Sources
- Deloose et al. 2012: the migrating motor complex, review (Nature Reviews Gastroenterology & Hepatology)
- Lacy et al. 2021: ACG clinical guideline on irritable bowel syndrome (American Journal of Gastroenterology)
- Wu et al. 2008: Ginger and gastric emptying in 24 healthy people, randomised trial (European Journal of Gastroenterology & Hepatology)
- Madisch et al. 2004: Herbal combinations STW 5 and STW 5-II in IBS, randomised trial of 208 people (Alimentary Pharmacology & Therapeutics)
- Andresen et al. 2024: herbal combination STW 5-II in functional dyspepsia, meta-analysis (Digestion)
- Leroy et al. 2022: Liver injury from Iberogast, case report (Gastro Hep Advances)
- Quigley et al. 2020: AGA expert review on small intestinal bacterial overgrowth (Gastroenterology)
- Pimentel et al. 2020: ACG clinical guideline on small intestinal bacterial overgrowth (American Journal of Gastroenterology)
- Su et al. 2018: meta-analysis, acid blockers increase the risk of SIBO (Journal of Gastroenterology)
- Lauritano et al. 2008: SIBO recurrence after antibiotics, 80 people over 9 months (American Journal of Gastroenterology)
- Wei et al. 2026: Hypothyroidism and risk of small intestinal bacterial overgrowth (Journal of Clinical Endocrinology & Metabolism)
- Vigone et al. 2017: Prucalopride for gut involvement in scleroderma, open-label PROGASS study (Arthritis Research & Therapy)
- Chang et al. 2023: Joint AGA/ACG guideline on the pharmacological treatment of chronic constipation
- Pimentel et al. 2009: Low-dose erythromycin or tegaserod after SIBO treatment, retrospective analysis (Gastroenterology & Hepatology)
- Ray et al. 2004: Erythromycin and the risk of sudden cardiac death (New England Journal of Medicine)
- Lembo et al. 2016: TARGET 3, relapse and repeat treatment with rifaximin in IBS with diarrhoea (Gastroenterology)
- Pimentel et al. 2002: Fewer cleaning waves in IBS with abnormal breath test, 68 people (Digestive Diseases and Sciences)
- Nieuwenhuijs et al. 1998: Morphine, the cleaning wave and bacterial growth in the small intestine, rat study (Annals of Surgery)
- Brechmann et al. 2017: risk factors for SIBO in 1,809 breath tests (World Journal of Gastroenterology)
- Revaiah et al. 2018: SIBO on acid blockers with and without a prokinetic, cross-sectional study of 147 people (JGH Open)
Your progress
Log in to mark chapters as read, rate them or report them for review. An account is optional and free.
Is something wrong here?
If you think something is wrong, outdated or misleading, report it for review. Every report is read and answered.
Log in to mark chapters as read, rate them or report them for review. An account is optional and free.